YOLARX researchers are co-authors of a poster “Effectiveness of Injectable Paliperidone Palmitate on Treatment Adherence and Relapse in the Adult Schizophrenia Population of Colombia: A Mirror-Image Single Center Study“ presented at the 2021 Virtual Conference of the Schizophrenia International Research Society on 18 April 2021.
You would like to integrate into a company that is constantly evolving, to join a young and dynamic team and to take on new challenges? Consult our job openings and submit your application to: firstname.lastname@example.org. Read more
YOLARX attended the virtual conference “ICPE 2020 – All Access” with several posters and one oral presentation. If you’d like to hear more, please contact us at: email@example.com. Read more
Prof. Moride, president and founder of YolaRx Consultants, will present “A Delphi Study on the development of a risk proportionality framework for the selection of risk minimisation interventions in Asia” at the 12th ACPE conference in Kyoto, Japan on Saturday, 12th October 2019.
YOLARX attended the ICPE 2019 with several posters. If you’d like to hear more, please contact us at: firstname.lastname@example.org. Read more
Prof. Moride, president and founder of YolaRx Consultants, presented “THE OPIOID CRISIS: Chronic opioid use in a universal health care setting following the implementation of risk communication” at the 1st ISOP Israel international symposium in Tel Aviv, Israel on Monday, 3rd of June, 2019.
The YOLARX team will be attending the 8th Annual Bordeaux Pharmacoepi Festival in Bordeaux, France on May 21st-23rd 2019. If you’re interested in meeting on site, please send us an email at: email@example.com.
Prof. Moride, President of YOLARX Consultants, attended the 9th Pharmaceutical Care Conference in Muscat. Prof. Moride presented on the pharmacovigilance analysis of product confusion errors and issues. Want to hear more about the conference? Send us an e-mail: firstname.lastname@example.org
Prof. Moride, President and Founder of YOLARX Consultants, presented at the Canadian Pharmacovigilance and Risk Management Strategies Conference held in Ottawa on October 29th, 2018. During this conference, Prof. Moride presented strategies and data sources to evaluate the effectiveness of risk minimization interventions for opioids. If you’d like to hear more, please contact us at: email@example.com
Prof. Moride, President and Founder of YOLARX Consultants, presented at the DIA Canadian Annual Meeting on October 30th, 2018 in Ottawa. Prof. Moride presented on the subject of the evaluation of the effectiveness of risk minimization activities.